Product Images Revatio
View Photos of Packaging, Labels & Appearance
- Instructions for Use Figure A - image 01
- Instructions for Use Figure B - image 02
- Instructions for Use Figure C - image 03
- Instructions for Use Figure D - image 04
- Instructions for Use Figure E - image 05
- Instructions for Use Figure F - image 06
- Instructions for Use Figure G - image 07
- Instructions for Use Figure H - image 08
- Instructions for Use Figure I - image 09
- Sildenafil Citrate Structural Formula - image 10
- Figure 1. Effects of Other Drugs on Sildenafil Pharmacokinetics - image 11
- Figure 2. Effects of Sildenafil on Other Drugs - image 12
- Figure 3. Change from Baseline in 6-Minute Walk Distance (meters) at Weeks 4, 8, and 12 in SUPER-1: Mean (95% Confidence Interval) - image 13
- Figure 4. Placebo-Corrected Change From Baseline in 6-Minute Walk Distance (meters) at Week 12 by Study Subpopulation in SUPER-1: Mean (95% Confidence Interval) - image 14
- Figure 5. Kaplan-Meier Plot of Time (in Days) to Clinical Worsening of PAH in PACES-1 - image 15
- Figure 6. Percentage Change from Baseline in VO2Peak: Mean (95% Confidence Intervals) - image 16
- Bottle Label Revatio 20 mg - image 17
- Carton Label Revatio 10 mg/12.5 mL - image 18
- Carton Label Revatio 10 mg/mL - image 19
Product Label Images
The following 19 images provide visual information about the product associated with Revatio NDC 58151-402 by Viatris Specialty Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Instructions for Use Figure A - image 01

This is a description of a bottle adaptor used for a REVATIO oral suspension. It includes a barrel, plunger, and indicates a "Discard after" date for the suspension. The image referred to as Figure A likely demonstrates the assembly or usage of the adaptor.*
Figure 1. Effects of Other Drugs on Sildenafil Pharmacokinetics - image 11

Interacting drug fold change and 90% CI recommendations are provided for various medications including Atorvastatin, Oral Contraceptives, Ritonavir, and Saquinavir. The text also mentions that no dose adjustments are required for Atorvastatin AUC. Additionally, it references the accumulation ratio of AUC from Day 1 to Day 7 relative to Sildenafil alone, and mentions that there is no benefit on exercise capacity when sildenafil is added to bosentan therapy.*
Figure 3. Change from Baseline in 6-Minute Walk Distance (meters) at Weeks 4, 8, and 12 in SUPER-1: Mean (95% Confidence Interval) - image 13

Figure 4. Placebo-Corrected Change From Baseline in 6-Minute Walk Distance (meters) at Week 12 by Study Subpopulation in SUPER-1: Mean (95% Confidence Interval) - image 14

Carton Label Revatio 10 mg/12.5 mL - image 18

This is a description of the drug Revatio (sildenafil) Injection, with a strength of 10 mg/12.5 mL. It is a sterile single-dose solution for intravenous use. The medication is stored at a controlled room temperature between 20°C to 25°C (68°F to 77°F). Each milliliter of the solution contains 1.124 mg of sildenafil citrate, 505 mg of dextrose, and water for injection. The drug is distributed by Vit Specialty LLC in Morgantown, WV, USA. The dosage information and prescribing details can be found in the accompanying literature.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.